Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH ...
Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.
Le Lézard5 天
Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference
Rocket Pharmaceuticals, Inc. , a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that ...
Rocket Pharmaceuticals Positioned for Growth with Promising Pipeline and Strategic Advancements
William Blair analyst Sami Corwin has maintained their bullish stance on RCKT stock, giving a Buy rating yesterday. Sami Corwin has given his ...
Strong Buy Recommendation for Rocket Pharmaceuticals Driven by Strategic Positioning and ...
Cory Jubinville, PhD, an analyst from LifeSci Capital, maintained the Buy rating on Rocket Pharmaceuticals (RCKT – Research Report). The ...
eLife6 天
Glucokinase activity controls subpopulations of β-cells that alternately lead islet Ca
This study provides convincing evidence for functional subpopulations of β-cells responsible for Ca2+ signal initiation and maintenance using novel three-dimensional light sheet microscopy imaging and ...